Litcius/Paper detail

Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology

Maxwell J. Lasko, David P. Nicolau

2020Current Infectious Disease Reports61 citationsDOIOpen Access PDF

Topics & Concepts

Ceftazidime/avibactamAntimicrobialCarbapenem-resistant enterobacteriaceaeMeropenemAntibiotic resistanceCarbapenemMedicineIntensive care medicineMicrobiologyPseudomonas aeruginosaBiologyEnterobacteriaceaeCeftazidimeAntibioticsBacteriaEscherichia coliGeneBiochemistryGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPharmaceutical and Antibiotic Environmental Impacts
Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology | Litcius